One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood.v128.22.792.792
Copy DOI Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 16 |
Affiliation: Praxis für Hämatologie und Onkologie, University of Adelaide, Seoul St. Mary's Hospital, Akita University, Jagiellonian University, Novartis (United States), Hospital Ramos Mejía, University of Bordeaux, Russian Research Institute of Hematology and Transfusiology, Hemorio, Mayo Clinic, Winneshiek Medical Center, Hospital das Clínicas da Universidade Federal de Minas Gerais, National Research Center for Hematology Russian Academy of Medical Sciences, Tris Pharma (United States), Novartis (France), Hôpital Lyon Sud, Novartis (India), Rambam Health Care Campus, Princess Margaret Cancer CentreTreatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
